Newer GLP-1 medications may reduce alcohol-related hospitalization risk
Researchers found semaglutide and tirzepatide were linked to 26% to 65% lower alcohol-related hospital admission risk across four trials.
8 Articles
8 Articles
Ozempic and Other GLP-1 Drugs for Alcoholism: Do They Work?
How Might GLP-1 Drugs Work for AUD? How They Work When it comes to weight loss, GLP-1 drugs work by mimicking a natural hormone in your body that controls appetite and blood sugar. This slows down how quickly food leaves your stomach, so you feel fuller longer and aren’t hungry as often.e60dc2a1-f33c-4a05-9b50-8e3e8e597629cf552d5b-b10f-4545-ae1d-da3d3caf3f3b Researchers don’t yet understand exactly how GLP-1 drugs work for AUD, according to …
GLP-1s for Addiction; DEA's Ketamine Crackdown; ADHD and Social Media
(MedPage Today) -- The use of GLP-1 receptor agonists was associated with a lower risk of alcohol-related hospitalization in adults with alcohol addiction, a retrospective study found. (BMJ Open) GLP-1 drugs for obesity were linked with reduced...
Born to treat diabetes, then proved revolutionary also to counter obesity, GLP-1 receptor agonist drugs, such as semaglutide and thyrzepatide, have now proved to be promising also for the treatment of alcohol addiction. A new research that involved several American centers, published in the magazine BMJ Open, indicates that these active substances could [...] The article "Slimming drugs with semaglutide and GLP-1 can fight alcoholism, shelters r…
Newer GLP-1 medications may reduce alcohol-related hospitalization risk
Use of newer GLP-1 receptor agonists (semaglutide or tirzepatide) for obesity or diabetes by people with alcohol-use disorder was associated with a reduction in alcohol-related admissions to hospital, finds a study published online in the open access journal BMJ Open.
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
